Nasdaq
$5.65▼ 0.88%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $68.7MShares out 12.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
4- 9.30After-hours26.10.01 05:1225-NSEOther#●●●
NutriBand Inc.Bullish
The Nasdaq Stock Market has officially notified the delisting of NutriBand Inc., with the removal from listing and registration effective as of September 30, 2026. Investors should note that trading of the security on the Nasdaq exchange has been terminated.…more
$5.65-0.88%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.23After-hours26.09.24 06:278-KKey event
NutriBand Inc.
Nutriband Inc. (NTRB) announced that its publicly traded warrants (NTRBW) will expire as scheduled on September 30, 2026, at 5:00 p.m. ET, with no extensions or repricing. Warrant holders may exercise their rights at a strike price of $6.43 per share until the deadline, after which any unexercised warrants will become void. This expiration does not impact the trading of the company's common stock.…more
$5.65-0.88%vs prev closeView filingShare - 9.15Regular26.09.16 04:48SCHEDULE 13D/AOwnership
NutriBand Inc.
This is a Schedule 13D/A filing by major shareholder Gareth Sheridan regarding their beneficial ownership in NutriBand Inc. The filing serves to update the SEC on changes in the reporting person's equity holdings.…more
$5.65-0.88%vs prev closeView filingShare
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.8Pre-market26.10.08 20:20#●●●#●●●
Nutriband Files New Patent for AVERSA Abuse Deterrent Technology
Nutriband has filed a new U.S. patent application to enhance and extend the protection of its AVERSA transdermal abuse-deterrent technology. If granted, the patent could extend intellectual property coverage for its drug delivery products until 2046.…more
$5.65-0.88%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.1After-hours26.10.02 05:05
●●●●●●●● ●●●●● ●●●●●●
Nutriband celebrated its five-year anniversary on the Nasdaq, highlighting key milestones and its commitment to advancing the AVERSA Fentanyl patch toward FDA approval. The company noted a cleaner capital structure following the expiration of 2021 warrants and remains focused on upcoming clinical studies and regulatory filings.…more
$5.65-0.88%vs prev close - 9.29Pre-market26.09.29 22:25
●●●●●●●● ●●●●● ●●●●●●
Nutriband's CEO appeared in a documentary to discuss the company's abuse-deterrent technology for addressing the U.S. opioid crisis. As this is a promotional appearance without immediate commercial or regulatory milestones, the impact on the stock remains neutral.…more
$5.65-0.88%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report